UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The... (continue reading...)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the Month of August 2026
Commission File Number: 001-43383
IQM Quantum Computers Oyj
(Translation of registrant’s name into English)
Keilaranta 19
FI-02150 Espoo
Finland
(Address of Principal Executive Office)
Indicate by check mark whether the... (continue reading...)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
OF THE SECURITIES EXCHANGE ACT OF 1934
August 2026
Commission File Number: 001-39466
XPENG INC.
No.10, Cencun Fengzhuang Avenue
Tianhe District, Guangzhou
Guangdong 510640
People’s Republic of China
(Address of principal executive offices)
Indicate by check mark whether the registrant... (continue reading...)
More SEC Filings
View Older Stories-
Form 6-K PEARSON PLC For: Aug 03
-
Form 10-Q Seaport Therapeutics, For: Jun 30
-
Form 8-K BCB BANCORP INC For: Aug 03
-
Form 10-Q Boardwalk Pipeline Partn For: Jun 30
-
Form 4 Star Bulk Carriers Corp. For: Jul 30 Filed by: Reskos Nikolaos
-
Form 8-K OCULAR THERAPEUTIX, INC For: Aug 03
-
Form 8-K SmartKem, Inc. For: Aug 03
-
Form 8-K TG THERAPEUTICS, INC. For: Aug 03
-
Form 8-K Tonix Pharmaceuticals For: Aug 03
-
Form 6-K Can-Fite BioPharma Ltd. For: Aug 03
-
Form 8-K Krystal Biotech, Inc. For: Aug 03
-
Form 10-Q Krystal Biotech, Inc. For: Jun 30
-
Form 8-K Seaport Therapeutics, For: Aug 03
-
Form 6-K PEARSON PLC For: Aug 03
-
Form 6-K COMPUGEN LTD For: Jun 30
-
Form 10-Q ALEXANDER TECH CORP For: Jan 30
-
Form 8-K Genprex, Inc. For: Aug 03
-
Form 10-Q Pharmaceutical Resource For: Jun 30
-
Form 1-A Tejascore Techsystems
-
Form 8-K D-Wave Quantum Inc. For: Aug 03
-
Form 8-K TWO HARBORS INVESTMENT For: Aug 03
-
Form SCHEDULE 13D Valion Bio, Inc. Filed by: 3i, LP
-
Form 8-K Autolus Therapeutics For: Jul 30
-
Form 8-K GLAUKOS Corp For: Aug 03
-
Form 4 FTAI Aviation Ltd. For: Jul 31 Filed by: Moreno David
-
Form 8-A12B Eos Energy Enterprises,
-
Form 8-K BioXcel Therapeutics, For: Jul 31
-
Form 8-K MARRIOTT INTERNATIONAL For: Aug 03
-
Form 6-K Luckin Coffee Inc. For: Aug 03
-
Form 6-K InMode Ltd. For: Aug 03
-
Form 8-K Public Policy Holding For: Aug 03
-
Form 13F-HR Rising Stella Capital For: Jun 30
-
Form 4 V F CORP For: Jul 31 Filed by: Darrell Bracken
-
Form 10-Q SUPERNUS PHARMACEUTICALS For: Jun 30
-
Form 6-K NATIONAL GRID PLC For: Aug 03
-
Form 6-K BROOKFIELD Corp /ON/ For: Aug 03
-
Form 6-K Vista Energy, S.A.B. de For: Aug 03
-
Form 10-Q ALEXANDER TECH CORP For: Oct 31
-
Form 6-K BioNTech SE For: Aug 03
-
Form 425 Indivior Pharmaceuticals Filed by: Indivior Pharmaceuticals, Inc.
-
Form 8-K SOUTHERN CO For: Aug 03
-
Form 8-K Indivior Pharmaceuticals For: Aug 03
-
Form 8-K SUPERNUS PHARMACEUTICALS For: Aug 03
-
Form DEFA14A SUPERNUS PHARMACEUTICALS
-
Form 425 SUPERNUS PHARMACEUTICALS Filed by: SUPERNUS PHARMACEUTICALS, INC.
-
Form 8-K Easterly Government Prop For: Aug 03
-
Form 8-K SUPERNUS PHARMACEUTICALS For: Aug 01
-
Form 10-Q ALEXANDER TECH CORP For: Jul 31
-
Form N-2/A Robinhood Ventures Fund
-
Form 425 Indivior Pharmaceuticals Filed by: Indivior Pharmaceuticals, Inc.

